How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC
George R. Simon, MD, FACP, FCCP
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
Ashwin Mehta, MD, MPH
Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)
Khurrum Qureshi, PharmD, BCOP
Lymphoma Data Science from Populations to Precision Medicine and Back
Dr. Christopher R. Flowers, MD, MS, FASCO
